Cambridge, MA, United States of America

Antonio Eric Barberio

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonio Eric Barberio: Innovator in Cytokine Therapy

Introduction

Antonio Eric Barberio is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on nanoparticles for cytokine therapy. With a total of 2 patents, Barberio is recognized for his advancements in delivering cytokines effectively to combat cancer.

Latest Patents

Barberio's latest patents focus on the development of layer-by-layer nanoparticles designed for cytokine therapy in cancer treatment. These patents disclose particles that deliver cytokines, such as IL-12, for therapeutic purposes. The particles consist of cytokines that are non-covalently bound to liposomes, which are further coated with polyelectrolytes. This innovative approach aims to enhance the efficacy of cancer treatments by improving the delivery mechanism of cytokines.

Career Highlights

Antonio Eric Barberio is affiliated with the Massachusetts Institute of Technology, where he continues to push the boundaries of research in cancer therapy. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from cancer.

Collaborations

Barberio has collaborated with notable colleagues, including Santiago Correa Echavarria and Mariane Bandeira Melo. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Antonio Eric Barberio stands out as an innovative inventor in the field of cytokine therapy, with a focus on enhancing cancer treatment through advanced nanoparticle technology. His contributions are paving the way for more effective therapeutic strategies in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…